Viewing Study NCT02916095


Ignite Creation Date: 2025-12-24 @ 1:39 PM
Ignite Modification Date: 2026-04-17 @ 10:15 PM
Study NCT ID: NCT02916095
Status: COMPLETED
Last Update Posted: 2020-09-03
First Post: 2016-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Kanitinib in Treating Patients With Advanced Solid Tumors
Sponsor: Beijing Konruns Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module